Perioral Dermatitis Treatment: Why the Best Evidence Is for Stopping, Not Starting

Marina Ivakhnenko

September 8, 2026

Chronic Perioral Flares, Demodex & Perioral Dermatitis, DEMODEX & SKIN CONDITIONS, Demodex vs Perioral Dermatitis, Differential Diagnosis, Facial Symptoms, Itchy Perioral Rash, Mouth Rash, Nose Fold Irritation, Persistent Redness, POD vs Rosacea, Prescription Therapies, Redness Around Mouth, Steroid Rebound, Symptoms & Clinical Signs, SYMPTOMS & SIGNS, TESTING & DIAGNOSIS, Topical Therapies, TREATMENT & PROTOCOLS, Treatment Protocols

Almost every skin condition gets treated by adding something. A cream, a serum, a tablet, a routine. Perioral dermatitis is the exception, and that is why so many people stay stuck in it for years.

The strongest evidence in perioral dermatitis treatment supports an approach with a slightly absurd name: zero therapy. You stop. You stop the steroid, you stop the heavy moisturiser, you stop the routine you have been layering on in an attempt to fix it. And in most cases the condition resolves on its own.

That is a genuinely difficult prescription to accept when your face is covered in small red bumps and something in your bathroom cabinet makes them fade within two days. So this article explains why the thing that helps is the thing that keeps it going.

Quick answer

Perioral dermatitis is an eruption of small red papules and pustules around the mouth, and often the nose and eyes, that characteristically spares a narrow rim of skin against the lip border. Topical corticosteroid use on the face is the most strongly supported causative factor. The best-evidenced perioral dermatitis treatment is zero therapy, meaning withdrawal of steroids and unnecessary topicals, with oral tetracyclines, topical pimecrolimus and topical erythromycin also well supported. Stopping the steroid usually triggers a rebound flare lasting a couple of weeks, and restarting at that point is the commonest reason the condition becomes chronic.

How to recognise it

Perioral dermatitis produces clusters of small red bumps, some of them pustular, around the mouth. It can also involve the folds beside the nose and the skin around the eyes, in which case it is called periorificial dermatitis. It usually burns or stings rather than itching, and the skin often feels tight and dry at the same time.

There is one feature that separates it from almost everything else on the face.

The spared rim around the lip border, the diagnostic sign guiding perioral dermatitis treatment
The papules crowd around the mouth but leave a clear band against the lip itself.

A narrow rim of skin immediately against the lip border stays clear. The eruption crowds up to it and stops. Clinicians look for that gap, because it is unusual: acne does not respect it, rosacea sits centrofacially rather than clustering around the mouth, and contact dermatitis from lip products usually involves the lip border rather than avoiding it.

If you are trying to work out what you are looking at in a mirror, that band is the single most useful thing to check.

What sets it off

Triggers and precipitants that shape perioral dermatitis treatment decisions
One factor has far stronger evidence behind it than the rest.

A systematic review of the condition found the strongest evidence supporting topical corticosteroid misuse as the principal causative factor. Not one contributor among many. The principal one.

Inhaled and intranasal corticosteroids are also implicated, which matters if you use an asthma inhaler or a nasal spray, because those are easy to forget when listing what you put near your face. Heavy occlusive moisturisers, thick foundations, fluoridated toothpaste and prolonged mask wear all appear in the literature as contributors.

Why the steroid is a trap rather than a mistake

Here is the part that makes this condition so persistent, and it is worth being precise about it because people blame themselves unfairly.

A topical steroid genuinely works on perioral dermatitis. Within a day or two the redness fades and the bumps flatten. That is a real pharmacological effect, not a placebo. So the natural conclusion is that you have found the answer, and you keep the tube.

What happens next is that the condition becomes dependent on it. Each time you stop, it flares. Each time you restart, it settles. The steroid has stopped being a treatment and has become a requirement, and the flare on stopping feels like proof that you still need it.

You do not. The flare is the withdrawal, not the disease returning to its natural state. That distinction is the whole of successful perioral dermatitis treatment, and we cover the mechanism behind it in detail in our guide to steroid induced rosacea, where the same three-phase pattern plays out across the whole face.

What the evidence supports

Evidence strength ranking for perioral dermatitis treatment options
Ranked by published evidence rather than by prescribing habit.

An evidence-based review of published therapies found the strongest support for zero therapy, oral tetracyclines, topical pimecrolimus and topical erythromycin.

Zero therapy means discontinuing the possible exacerbants, principally topical corticosteroids and cosmetics, and letting the condition run its course. Most cases are self-limited once that is done.

Oral tetracyclines have the best trial evidence among active treatments and significantly shorten time to resolution. Reported regimens have used tetracycline at 250 to 500 mg twice daily, with clearance in the region of four to eight weeks compared against placebo. Doxycycline and minocycline are used similarly in practice. These are prescription decisions and tetracyclines are not suitable for young children or in pregnancy.

Topical pimecrolimus is interesting for a specific reason. It does not appear to shorten time to complete resolution, but it reduces severity rapidly, and it does so particularly in people whose condition followed prior corticosteroid use. For the person facing a bad rebound, that is the relevant property.

Topical erythromycin also reduces time to resolution, more slowly than oral tetracyclines.

Topical metronidazole deserves a note, because it is prescribed constantly for this condition, especially in children. Its evidence is weaker than its reputation: mainly case series, plus a trial finding it inferior to tetracycline. It is not a bad choice, particularly where an oral antibiotic is unsuitable. It is simply not the strongly evidenced choice many people assume.

Azelaic acid, adapalene and oral isotretinoin in resistant cases all appear in the literature as promising and all are flagged as needing more robust investigation. Our guide to isotretinoin covers what that drug does and does not change.

How zero therapy actually runs

Four-step zero therapy protocol for perioral dermatitis treatment including the rebound phase
Step three is where almost everyone abandons the plan.

The mechanics of perioral dermatitis treatment matter more than the concept, because the concept is easy and the execution is not.

Every facial steroid comes off. That includes the ones you have forgotten about: a tube prescribed for a partner, an old cream for a different problem, hydrocortisone borrowed for an insect bite. If you use an inhaled or nasal steroid, mention it to your prescriber rather than stopping it yourself, because that is a different risk calculation entirely.

The routine comes down to almost nothing. A gentle cleanser and, if the skin feels tight, one bland moisturiser. No acids, no retinoids, no vitamin C, no heavy balms, no occlusive foundation. Some clinicians also suggest switching away from fluoridated toothpaste for a period.

Expect the rebound and plan for it. Withdrawal typically produces a flare lasting around two weeks. It will look worse before it looks better. This is the single most important thing to know in advance, because a person who has been warned gets through it and a person who has not restarts the steroid on day four.

Bridge it if the rebound is severe. Where withdrawal is unmanageable, an oral tetracycline is the best-evidenced bridge. Some clinicians use a short course of a low-potency steroid such as hydrocortisone to soften the transition, though that is a judgement call and is not universally advised.

What it is not

Because the eruption is small, red and bumpy, it gets called acne more often than anything else, and acne treatment makes it worse. A few distinctions worth holding.

Acne produces comedones, the blackheads and whiteheads that perioral dermatitis does not make. It also has no reason to spare the lip border, and it usually involves the forehead and jawline rather than crowding around the mouth.

Contact dermatitis from a lip balm, toothpaste or lipstick tends to involve the vermilion border and the lip itself, which is the opposite of the perioral pattern. It is also more likely to be genuinely itchy rather than burning.

Seborrheic dermatitis favours the nasolabial folds, eyebrows and hairline, and it scales. Perioral dermatitis papules sit on skin that may be dry but is not typically greasy-scaled in the same way.

Rosacea is centrofacial, brings flushing and often visible vessels, and does not cluster around the mouth in the same ring.

The complication is that these can coexist, and a person with months of steroid exposure may genuinely have two things happening at once. That is a reason to get assessed rather than to self-diagnose from a list.

Perioral dermatitis in children

Children get this too, and the picture differs enough to be worth naming. In children it is more often described as periorificial dermatitis, because involvement around the eyes and nose is common alongside the mouth.

There is also a distinct granulomatous variant seen predominantly in children, which produces firmer, flesh-coloured or yellow-brown papules rather than the classic inflammatory ones.

The treatment considerations change in two ways. Oral tetracyclines are not suitable under the age of eight because of effects on developing teeth and bone, which removes the best-evidenced systemic option and is a large part of why topical metronidazole is prescribed so widely in this group despite thinner evidence. And inhaled corticosteroids for asthma are a common exposure in children, which needs to be raised with the prescribing clinician rather than stopped independently.

The core principle holds regardless of age: perioral dermatitis treatment in children still starts with removing the topical steroid and simplifying what goes on the face.

Where Demodex fits in

Perioral dermatitis, rosacea and mite-associated facial inflammation share a great deal: the same territory, a similar papulopustular appearance, and the same history of steroid exposure. Demodex appears explicitly in the modern literature on perioral dermatitis as a proposed contributor.

The connection is not mysterious. Topical corticosteroids suppress local immune surveillance in the skin, and reduced surveillance permits follicular microbial overgrowth, including a rise in Demodex density. So a person who has used facial steroids for months has both the perioral eruption and, frequently, a raised mite burden underneath it.

This is why some people clear on zero therapy alone and others plateau. If the eruption improves substantially but leaves a stubborn papulopustular remainder, particularly in the nasolabial folds and central face, that remainder is worth assessing rather than treating as residual perioral dermatitis. Our guide to how rosacea is now classified covers why appearance alone is a poor guide here, and the lupus comparison shows how much overlaps in this region of the face.

For practitioners

Hall and Zug’s evidence-based review found the strongest support for zero therapy, oral tetracycline, topical pimecrolimus and topical erythromycin, with topical metronidazole supported only by case series plus a trial showing inferiority to tetracycline. A later systematic review identified topical corticosteroid misuse as the principal causative factor and flagged tetracyclines, topical metronidazole, azelaic acid, adapalene and oral isotretinoin as requiring more robust study.

Counselling point that determines outcome: name the rebound in advance, give it a duration, and agree what the patient will do when it happens. Most treatment failure in this condition is not pharmacological, it is the unwarned patient restarting a topical steroid during predictable withdrawal.

Pimecrolimus is worth remembering specifically for the post-corticosteroid subgroup, where its rapid severity reduction addresses the exact phase that drives relapse, even though it does not shorten time to complete resolution. Note also that calcineurin inhibitors themselves appear in drug-induced rosacea reviews as a less common precipitant, so they are a bridge rather than a standing therapy.

Where a papulopustular remainder persists after adequate withdrawal, consider standardised skin surface biopsy before attributing it to incomplete resolution, given the documented rise in follicular mite density under prolonged topical corticosteroid exposure.

Frequently asked questions

How long does perioral dermatitis take to clear?

With zero therapy, most cases are self-limited over some weeks, with a rebound flare of roughly two weeks at the start. Oral tetracyclines shorten this, with reported clearance in the region of four to eight weeks.

Will hydrocortisone help my perioral dermatitis?

It will help in the short term and that is precisely the problem. Topical corticosteroid use on the face is the most strongly supported causative factor for the condition, and each course makes the next withdrawal harder.

Why did it get worse when I stopped the steroid?

That is the rebound, and it is expected. It is a withdrawal phenomenon rather than the condition worsening, and it typically lasts around a fortnight. Knowing that in advance is what allows people to get through it.

Is perioral dermatitis the same as rosacea?

No, though they overlap and can coexist. Perioral dermatitis clusters around the mouth and spares the lip border. Rosacea is centrofacial, involves the cheeks and nose, and features flushing and often telangiectasia.

Can toothpaste cause it?

Fluoridated toothpaste appears in the literature as a possible contributor, though the evidence is much weaker than that for topical corticosteroids. A trial switch is low-cost and reasonable, but it is not where the main gain lies.

Does it leave scars?

Perioral dermatitis does not usually scar. It can leave post-inflammatory redness or pigmentation for a period after the papules resolve, which fades with time and sun protection.

References

  1. Hall CS, Zug KA. Perioral dermatitis: an update including origin, causes, and treatment. Evidence based review of perioral dermatitis therapy. Giornale Italiano di Dermatologia e Venereologia, 2010. PMID 20823788.
  2. Searle T, Ali FR, Al-Niaimi F. Perioral dermatitis: diagnosis, proposed etiologies, and management. Journal of Cosmetic Dermatology, 2021. PMID 33751778.
  3. Tempark T, Shwayder TA. Perioral dermatitis: a review of the condition with special attention to treatment options. American Journal of Clinical Dermatology, 2014;15(2):101-113. PMID 24623018.
  4. Lipozencic J, Ljubojevic S. Perioral dermatitis. Clinics in Dermatology, 2011;29(2):157-161.
  5. Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: a long overdue revisit. Indian Dermatology Online Journal, 2014;5(4):416-425. PMC4228634.
  6. Rijal H, Geng R, Wilken B, Slomovic J, Sibbald C. Drug-induced rosacea: a systematic review. Journal of Cutaneous Medicine and Surgery, 2024.
  7. Karabay EA, Aksu Cerman A. Demodex folliculorum infestations in common facial dermatoses. Anais Brasileiros de Dermatologia, 2020. PMC7175027.

Selected sources: Hall and Zug evidence-based review (PubMed) and Searle 2021 systematic review (PubMed).

Bumps around the mouth that clear on a steroid and return every time you stop? Our symptom self-assessment works through the discriminating features, and the practitioner directory lists clinicians who assess for mite involvement alongside the eruption itself.


About the author. Marina Ivakhnenko is a functional skin practitioner focused on Demodex-associated and inflammatory facial skin conditions. This article is educational and is not a substitute for individual medical care. Do not stop a prescribed inhaled or systemic corticosteroid without speaking to your prescriber.

Written by Marina Ivakhnenko — licensed aesthetician, nutritionist and Functional Diagnostic Nutrition Practitioner (FDN-P), with a biology background from Florida Atlantic University. Author of The Demodex Solution.

She works with Ovante, a skincare brand formulating for Demodex-prone, rosacea-prone and folliculitis-prone skin since 1992, and created Rosacea Decoded, a program for rosacea and reactive skin.

Demodex.net is published by the team behind Ovante. Articles here are educational and are not a substitute for care from a physician or dermatologist.

DEMODEX QUIZ

Determine your mite density and get a personalized treatment protocol in 2 minutes.

JOIN OUR COMMUNITY

Connect with 15,000+ members in our private support group.

JOIN OUR COMMUNITY

Latest post

Chronic Inflammation, Demodex & Gut Health, Digestive Triggers, Food Sensitivities, Functional Medicine Evidence, Functional Testing, Gut Dysbiosis, Gut-Skin Axis, Leaky Gut, PubMed Research
Marina Ivakhnenko

●

November 4, 2026

Leaky Gut and Rosacea: What the Evidence Shows, and What to Test Instead

Leaky gut and rosacea: two small zonulin studies, a common
Bacterial vs Demodex, Demodex & Folliculitis, Demodex & Scalp Folliculitis, Demodex vs Folliculitis, Dermoscopy, Fungal vs Demodex, Itchy Scalp, Recurrent Folliculitis, Scalp Bumps, Scalp Symptoms, Severe Scalp Inflammation, Shampoo Protocols, Sulfur
Marina Ivakhnenko

●

November 4, 2026

Scalp Folliculitis: Nine Causes That Look the Same, and How to Tell Yours Apart

Scalp folliculitis is a pattern with at least nine causes.
Azelaic Acid, Clinical Trials, Demodex & Rosacea, DEMODEX & SKIN CONDITIONS, Demodex Diagnosis & Testing, Dermatology Studies, Dermoscopy, Ivermectin, Metronidazole, Papulopustular Rosacea, Persistent Redness, Prescription Therapies, Research & Clinical Studies, RESEARCH & SCIENCE, Rosacea Maintenance, Rosacea Relapse, Symptoms & Clinical Signs, SYMPTOMS & SIGNS, TESTING & DIAGNOSIS, Topical Therapies, TREATMENT & PROTOCOLS, Treatment Protocols
Marina Ivakhnenko

●

September 28, 2026

Ivermectin vs Metronidazole for Rosacea: Who Wins, and Who Needs Which

Ivermectin vs metronidazole is not a simple win. The head-to-head
Demodex & Autoimmune Conditions, Demodex & Immune Dysregulation, Demodex & Seborrheic Dermatitis, DEMODEX & SKIN CONDITIONS, Demodex Diagnosis & Testing, Demodex vs Contact Dermatitis, Demodex vs Seborrheic Dermatitis, Differential Diagnosis, Facial Symptoms, Functional Testing, Prescription Therapies, Skin Scraping, Symptoms & Clinical Signs, SYMPTOMS & SIGNS, TESTING & DIAGNOSIS, TREATMENT & PROTOCOLS, Unexplained Inflammation
Marina Ivakhnenko

●

September 28, 2026

Dupilumab Facial Redness: Yeast, Mite, or Something Else?

Dupilumab facial redness is not one condition. Yeast, Demodex mites,
Burning & Stinging, Chronic Failed Treatment, Demodex & Autoimmune Conditions, Demodex & Chronic Inflammation, Demodex & Perioral Dermatitis, Demodex & Rosacea, DEMODEX & SKIN CONDITIONS, FAQS & QUICK ANSWERS, Papulopustular Rosacea, Persistent Redness, Prescription Therapies, Red Flags & Doctor Referral, Rosacea Flushing, Rosacea Recovery, Rosacea Relapse, Steroid Rebound, Steroid-Induced Demodex, Symptoms & Clinical Signs, SYMPTOMS & SIGNS, Topical Therapies, TREATMENT & PROTOCOLS, Treatment Protocols
Marina Ivakhnenko

●

September 8, 2026

Steroid Induced Rosacea: Why the Cream That Worked Is the Reason It Will Not Stop

Steroid induced rosacea is not the steroid masking a condition.
Chronic Perioral Flares, Demodex & Perioral Dermatitis, DEMODEX & SKIN CONDITIONS, Demodex vs Perioral Dermatitis, Differential Diagnosis, Facial Symptoms, Itchy Perioral Rash, Mouth Rash, Nose Fold Irritation, Persistent Redness, POD vs Rosacea, Prescription Therapies, Redness Around Mouth, Steroid Rebound, Symptoms & Clinical Signs, SYMPTOMS & SIGNS, TESTING & DIAGNOSIS, Topical Therapies, TREATMENT & PROTOCOLS, Treatment Protocols
Marina Ivakhnenko

●

September 8, 2026

Perioral Dermatitis Treatment: Why the Best Evidence Is for Stopping, Not Starting

The best-supported perioral dermatitis treatment is removing things, not adding